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Abstract
 
Dendritic cells (DCs) are essential for the early events of human immunodeficiency virus (HIV)
infection. Model systems of HIV sexual transmission have shown that DCs expressing the DC-
specific C-type lectin DC-SIGN capture and internalize HIV at mucosal surfaces and effi-
ciently transfer HIV to CD4
 
 
 
 T cells in lymph nodes, where viral replication occurs. Upon
DC–T cell clustering, internalized HIV accumulates on the DC side at the contact zone (infec-
tious synapse), between DCs and T cells, whereas HIV receptors and coreceptors are enriched
on the T cell side. Viral concentration at the infectious synapse may explain, at least in part,
why DC transmission of HIV to T cells is so efficient.
Here, we have investigated the role of DC-SIGN on primary DCs in X4 HIV-1 capture and
transmission using small interfering RNA–expressing lentiviral vectors to specifically knock-
down DC-SIGN. We demonstrate that DC-SIGN
 
 
 
 DCs internalize X4 HIV-1 as well as
DC-SIGN
 
 
 
 DCs, although binding of virions is reduced. Strikingly, DC-SIGN knockdown
in DCs selectively impairs infectious synapse formation between DCs and resting CD4
 
 
 
 T
cells, but does not prevent the formation of DC–T cells conjugates.
Our results demonstrate that DC-SIGN is required downstream from viral capture for the
formation of the infectious synapse between DCs and T cells. These findings provide a novel
explanation for the role of DC-SIGN in the transfer and enhancement of HIV infection from
DCs to T cells, a crucial step for HIV transmission and pathogenesis.
Key words: HIV/SIV • virological synapse • RNA interference • lentiviral vectors • 
trans infection
 
Introduction
 
The major mode of HIV propagation worldwide is through
sexual transmission. Model systems of HIV sexual transmission
have shown that small amounts of virus cross mucosal surfaces
and are captured by DCs to reach replication-competent sites
in lymphoid tissue (for review see references 1–4). Direct in-
fection of specific DC subsets by HIV is well demonstrated
in vitro, at least with large amounts of virus. However,
HIV/SIV-infected DCs are rarely detected in vivo (3).
HIV can take an alternative route. DCs capture and store
HIV in an intracellular compartment in the absence of viral
replication and subsequent present infectious virions to T
cells (5–7). Whether sexual transmission of HIV is medi-
ated by direct infection of DCs and/or via the capture
pathway remains unresolved (reference 8 and for review
see references 1, 3, 4, 9)
In addition to classical HIV receptors and coreceptors
(CD4, CCR5, and CXCR4), DCs express a type II trans-
membrane protein with an external C-type lectin domain,
DC-SIGN (CD209), that captures and transmits HIV to T
cells (10–12). DC-SIGN is expressed on the surface of sev-
eral subsets of immature and, to a lesser extent, mature DCs
(13, 14). The natural ligands for DC-SIGN are ICAM-3
and ICAM-2, molecules that contribute to transient DC–T
cell attachment (13) and to transmigration of DCs across the
vascular endothelium (15), respectively. Some DC subsets,
such as Langerhans cells, do not express DC-SIGN, but
they may use additional molecules such as Langerin, another
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C-type lectin, to bind and transmit HIV to T cells (14, 16).
Currently, DC-SIGN is the only known C-type lectin that
enhances transmission from DCs to T cells (10, 17).
DC-SIGN and its homologue L-SIGN (CD209L/DC-
SIGNR) function as attachment factors for HIV-1, HIV-2,
and SIV (11, 18, 19). In fact, DC-SIGN binds gp120 with
high affinity (20).
Interestingly, DC-SIGN–associated virus remains infec-
tious for prolonged periods of time in the absence of repli-
cation within DCs (10, 21, 22). Although professional
APCs such as DCs are rich in degradative compartments
that are important in antigen processing, and some degra-
dation of HIV-1 occurs, DCs appear unable to completely
digest this virus (8, 17, 23). The mechanisms that mediate
the prolonged survival or the increase in infectivity of viri-
ons captured by DCs via DC-SIGN are unclear at present,
but may involve trafficking of HIV through a nonlysosomal
endosomal compartment that has yet to be fully defined
(17, 24, 25). These data are supported by results demon-
strating that trypsin treatment of HIV-exposed DCs does
not decrease the efficiency of DC-mediated virus transmis-
sion to T cells (26).
After encountering CD4
 
 
 
 T cells, virions internalized by
DCs relocalize to sites of contact with T cells at the infec-
tious synapse (references 8, 27 and for review see reference
28). Infectious synapse formation is likely to be initiated by
a normal cellular process in which DCs form transient con-
tacts with T cells without the requirement for antigen
specificity. Subsequently, T cells perform a “scanning” to
enable recognition of any cognate peptide specificities
presented by the APC (29, 30). In DC–T cell conjugates,
HIV-1 virions internalized by DCs concentrate at the con-
tact surface with the T cell, whereas the HIV-1 receptors
CD4 and CCR5 appear to be partially enriched on the T
cell at the site of contact with the DC (27). Viral receptor
recruitment and virus focusing at this synapse may explain,
at least in part, why DC transmission of HIV to T cells is
such an efficient process (5, 10, 31). However, mechanisms
of DC–T cell infectious synapse formation remain elusive.
To analyze the role of DC-SIGN in infectious synapse
formation, we disrupted the expression of this C-type lec-
tin with lentiviral vectors (LV-si-SIGN) stably express-
ing small interfering (si)RNA targeting DC-SIGN. DCs
knocked down for DC-SIGN enabled us to define the se-
quential role of this receptor in HIV attachment (X4 HIV-1),
internalization, and transfer of viral infectivity from DCs
to CD4
 
 
 
 T cells through an infectious synapse. Although
DC-SIGN contributes significantly to X4 HIV-1 binding
on DCs at 4
 
 
 
C, viral capture and internalization by DCs at
37
 
 
 
C after 2 h is similar in presence or absence of DC-
SIGN. Importantly, DC-SIGN knockdown DCs are selec-
tively impaired for the formation of infectious synapses be-
tween DCs pulsed with X4 HIV-1 and uninfected CD4
 
 
 
resting T cells. Nevertheless, DC-SIGN
 
 
 
 DCs retain their
capacity to form conjugates with resting CD4
 
 
 
 T cells. As a
consequence, transfer of X4 HIV-1 infection by DC-
SIGN
 
 
 
 DCs to target cells is severely impaired (down-
stream of viral capture). Together, these results identify the
C-type lectin DC-SIGN as an important component of the
infectious synapse that facilitates transfer of X4 HIV-1 in-
fection from DCs to T cells.
 
Materials and Methods
 
Vectors Construction and siRNA.
 
Lentivectors and siRNA se-
quences used in this work have been described previously (32).
LV-si-SIGN11 is an efficient siRNA-expressing lentivector enabling
stable DC-SIGN and L-SIGN knockdown (32). LV-si-SIGN8
is an siRNA-expressing lentivector enabling stable specific
DC-SIGN (and not L-SIGN) knockdown (32). LV-si-SIGN26 is
an inefficient siRNA-expressing lentivector (32)
 
Production of Lentiviral Vectors.
 
The 293T and HeLa cell lines
were cultured in Dulbecco’s modified Eagle’s medium supple-
mented with 10% FCS. All recombinant lentiviral vectors were
produced by transient transfection of 293T cells according to
standard protocols (33) as described previously (32). Vector titers
were determined by transduction and flow cytometry analysis of
GFP expression in HeLa cells. Titers ranged between 2 
 
 
 
 10
 
7
 
and 5 
 
 
 
 10
 
8
 
 HeLa transducing units per milliliter.
 
Preparation and Transduction of DC Progenitors.
 
Cord blood
samples were obtained according to institutional guidelines of the
ethical committee. CD34
 
 
 
 cells were purified and cultured as de-
scribed previously (34). DC progenitors were transduced and an-
alyzed on a FACSCalibur cell analyzer (Becton Dickinson) as re-
ported previously (35) with some modifications (32). After 3–6
wk of primary culture, DC progenitors were transduced with
LV-si-SIGN lentivectors at an MOI of 20 and were induced to
differentiate into immature DCs for 6 d with 50 ng/ml GM-CSF
and IL-4 or into mature DCs by further addition of LPS for the
last 2 d. DCs were harvested at day 6, analyzed by flow cytome-
try and used in subsequent assays. Additional technical details
have been described previously (32).
 
Flow Cytometric Analysis and Monoclonal Antibodies.
 
Flow cy-
tometric analysis was performed as described previously (36).
Cells were analyzed on a FACScalibur cell analyzer (Becton
Dickinson). Data were analyzed using WINMDI software by J.
Trotter (The Scripps Institute, La Jolla, CA). All antibodies have
been described previously (32).
 
Cellular Sorting.
 
Immature or mature DCs were sorted on a
FACSVantage SE cell sorter (Becton Dickinson) as GFP
 
 
 
 DC-
SIGN
 
 
 
 cells (LV-si-SIGN11) using PE-labeled anti–DC-SIGN
mAb or GFP
 
 
 
 cells (empty vector). Cells were systematically re-
analyzed after sorting using allophycocyanin-labeled anti–DC-
SIGN mAb.
 
Viral Stocks.
 
Viral stocks were generated by transfection of
293T cells with calcium-phosphate coprecipitated proviral plas-
mid pR9, which encodes for a full length HIV-1 X4 strain (37),
or pR9 IN-HA, which encodes for a full length infectious HIV-1
X4 strain provirus bearing an HA-tagged integrase (a gift from F.
Bushmann, Salk Intitute, La Jolla, CA). Infectious titer of viral
stocks was evaluated by limiting dilution on CD4
 
 
 
 HeLa P4-2
cells containing 
 
 
 
-gal
 
 gene under the control of the HIV pro-
moter, expressed as infectious units per milliliter, which gives us
values of MOI. Alternatively, titer values were determined by
measuring HIV-1 p24
 
gag
 
 using an ELISA kit (Beckman Coulter).
GFP-labeled HIV-1 X4 strain (HIV W-xxF-GFP) has been de-
scribed previously (38).
 
Viral Binding and Capture Assays
 
Sorted transduced DCs or
Raji cell lines (8 
 
 
 
 10
 
4
 
 cells/well) were incubated with HIV-1 
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X4 (100 ng of p24
 
gag
 
 or approximately an MOI of 1) in 80 
 
 
 
l of
total volume for 2 h at 4
 
 
 
C. Viral binding assays were performed
with stably siRNA-expressing Raji cell lines described previously
(32) or with DCs transduced with empty vector or LV-si-
SIGN11. Untransduced DCs were also incubated in the presence
of 1 mg/ml mannan for 30 min at 37
 
 
 
C before virus exposure for
2 h at 4
 
 
 
C. Cells were vigorously washed seven times with cold
PBS 
 
 
 
 1% HSA interspersed with centrifugations to remove un-
adsorbed virus, and finally lysed with 50 
 
 
 
l of PBS containing 1%
Triton X-100. The p24
 
gag
 
 content of the lysate was determined
by ELISA. Results were expressed as percentage of p24
 
gag
 
 binding
in control cells (Raji-LV-DC-SIGN or untransduced DCs).
For viral capture assays at 37
 
 
 
C, transduced DCs (2.5 
 
 
 
 10
 
5
 
cells/well) were incubated with HIV-1 X4 (MOI 1) in 80 
 
 
 
l of
total volume for 2 h at 37
 
 
 
C. Simultaneous labeling of surface
DC-SIGN and intracellular p24
 
gag
 
 was performed using allophy-
cocyanin-coupled anti–DC-SIGN mAb, and subsequent intra-
cellular staining of HIV-1 p24
 
gag
 
 was performed using Cytofix-
Cytoperm (BD Biosciences) and PE-coupled anti-p24
 
gag
 
 mAb
(clone KC57 RD1; Beckman Coulter). Cells were washed, fixed
in 1% paraformaldehyde and analyzed using a FACScalibur.
 
Analysis of DC-SIGN–mediated Transfer of HIV Infection to Target
Cells.
 
The ability of Raji transfectants and DCs to transfer virus
particles to target cells was determined by coculturing HIV-
pulsed cells with CD4
 
 
 
 HeLa P4-2 cells in 24-well plates in a
single round assay. In brief, virus-pulsed Raji or DCs were
washed extensively to remove unadsorbed virus, and 1,000 Raji
or DCs were cocultured with CD4
 
 
 
 HeLa P4-2 cells. Viral trans-
fer was determined by measuring the number of CD4
 
 
 
 HeLa P4-2
infected cells. Results were expressed as percentage of each con-
dition compared with control cells (Raji-LV-DC-SIGN or empty
vector-transduced DCs).
 
Immunofluorescence Microscopy, Infectious Synapse Assay, and
DC–T Cell Clusters Formation Assays.
 
Highly purified resting
CD4
 
 
 
 T cells were prepared as described previously (39), result-
ing in a population of resting CD4
 
 
 
 T cells with a degree of pu-
rity superior to 95% as determined by postpurification FACS anal-
ysis. For infectious synapse assays, 3 
 
 
 
 10
 
5
 
 CD4
 
 
 
 T cells were left
to adhere on poly-
 
l
 
-lysine-treated glass coverslips for 2 h at 37
 
 
 
C.
Mature sorted DCs (10
 
5
 
 cells) were pulsed with HIV IN-HA for
2 h at 37
 
 
 
C (MOI 
 
 
 
 5). DCs were washed twice and left to ad-
here at 37
 
 
 
C on coverslips for 10 or 30 min to allow contact with
previously seeded T cells. Cells were fixed by a 20-min incuba-
tion in 3% paraformaldehyde at room temperature, further per-
meabilized with 0.05% saponin, and washed several times with
PBS containing 10% FCS and human IgG (20 
 
 
 
g/condition).
Cells were stained with primary mouse anti–HA-11 mAb (dilu-
tion of 1:1,000; Covance-Babco) and secondary donkey anti–
mouse coupled to rhodamine (Jackson ImmunoResearch Labora-
tories) (dilution of 1:500). Nuclei were stained with DAPI
(Molecular Probes). Samples were analyzed on an Axiovert 200
fluorescence microscope (Carl Zeiss MicroImaging, Inc.) equipped
with a cooled charge–coupled device camera as described previ-
ously (40). We measured an infectious synapse as a DC–T cell
conjugate where the majority of HIV is focused at the zone of
contact with the CD4
 
 
 
 T cells (
 
 
 
75% of HIV), which can be
readily determined by immunofluorescence microscopy. We im-
aged and quantified in each experiment 
 
 
 
60–70 DC–T cell con-
jugates for the 10-min time point and 170–180 DC–T cell con-
jugates for the 30-min time point (see Fig. 6 B).
For HIV and DC-SIGN colocalization in the infectious syn-
apse, mDCs (10
 
5
 
 cells) were loaded with a GFP-labeled HIV-1
X4 for 2 h (MOI 
 
 
 
 10) and left to adhere on coverslips for 30
min at 37
 
 
 
C to allow contact with previously seeded T cells as
described before. Cells were fixed, permeabilized, and stained
with primary anti–DC-SIGN mAb (dilution of 1:5) (clone
120507; R&D Systems) and secondary donkey anti–mouse cou-
pled to rhodamine. Mounted slides were examined on an Axio-
vert 200 fluorescence microscope (Carl Zeiss MicroImaging,
Inc.). Confocal laser scanning microscopy was performed with a
Nipkow QLC100 module (Visitron Systems).
DC–T cell conjugate formation was quantified by counting
DC–T cell conjugates on the whole surface of coverslips prepared
for the infectious synapse assay. Alternatively, DC–T cell cluster
formation was measured by flow cytometric analysis. For this pur-
pose, empty vector- or LV-si-SIGN11-transduced DCs were la-
beled with anti–CD1a-APC and incubated over time with CD4
 
 
 
T cells labeled with anti–CD3-PE or with the fluorescent dye
PKH26 (Sigma-Aldrich). Flow cytometric analysis of DC–T cell
cluster formation was performed by determining the percentage of
PKH
 
 
 
 cells within each GFP
 
 
 
CD1a
 
 
 
 cellular population using a
FACScalibur cell analyzer. This method allowed us to measure
triple positive (PKH
 
 
 
GFP
 
 
 
CD1a
 
 
 
) DC–T cell conjugates.
Figure 1. Generation of DCs knocked down for DC-SIGN expression.
(A) DC progenitors were transduced with the indicated lentiviral vectors
and differentiated into mature DCs. GFP  DCs were sorted for empty
vector-transduced cells (left), whereas GFP  DC-SIGN  cells were
sorted for LV-si-SIGN11 (right). Cell percentages corresponding to each
quadrant of two-dimensional plots are shown. One representative experi-
ment out of eight is shown. (B) Percentage of DC-SIGN expression is
shown for each sorted GFP  cellular population. Means   SEM of eight
independent experiments is shown. 
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Results
 
Transduction of DC Progenitors with siRNA-expressing Lentivi-
ral Vectors Allows Generation and Sorting of DC-SIGN
 
 
 
 DCs.
 
Recently, we reported an experimental system that allows us
to generate human DCs stably knockdown for DC-SIGN
expression (32). DC progenitors are amplified in vitro from
cord blood CD34
 
 
 
 cells with Flt3-ligand, stem cell factor,
and thrombopoietin. Subsequently, they are transduced with
siRNA-expressing lentiviral vectors targeting DC-SIGN ex-
pression. Transduced DC progenitors are induced to differ-
entiate either into immature DCs for 6 d with GM-CSF and
IL-4, or into mature DCs by addition of LPS for the last 2 d.
We have identified an siRNA-expressing lentiviral vector
(LV-si-SIGN11) that very potently inhibits DC-SIGN ex-
pression (32). Sorting of DCs with surface DC-SIGN
knockdown is facilitated by GFP expression of transduced
cells (Fig. 1). As shown in Fig. 1 A, GFP
 
 
 
 cells are selected
in the case of empty vector-transduced DCs, whereas gat-
ing is performed on GFP
 
 
 
 DC-SIGN
 
 
 
 cells for LV-si-
SIGN11–transduced DCs (top right). Flow cytometric anal-
ysis of sorted cellular populations for GFP and DC-SIGN
expression is shown in Fig. 1 A (bottom). DC-SIGN ex-
pression was 75.7 
 
 
 
 4.9% in empty vector-transduced DCs
with a mean fluorescence intensity between 10
 
2
 
 and 10
 
3
 
 and
2.6 
 
 
 
 0.6% in LV-si-SIGN11–transduced DCs with a mean
fluorescence intensity close to background values (mean 
 
 
 
SEM, 
 
n
 
 
 
  
 
8; Fig. 1 B). In conclusion, this experimental sys-
tem allows us the generation and selection of primary DCs
that are negative for DC-SIGN expression.
 
DC-SIGN Contributes to HIV Binding on DCs, But Not to
HIV Capture and Internalization.
 
To evaluate the contri-
bution of DC-SIGN for HIV attachment on DCs, we per-
formed binding assays at 4
 
 
 
C using an X4 viral strain and
measured virion binding to DCs by p24
 
gag
 
 ELISA. Attach-
ment of HIV on DC-SIGN
 
 
 
 DCs at 4
 
 
 
C was reduced by
 
 
 
40%, whereas the carbohydrate mannan decreased HIV
binding to DCs by 60% (Fig. 2 A). Viral attachment to
DC-SIGN knockdown Raji transfectants was severely de-
creased by 80% (Fig. 2 A).
Next, we examined whether DC-SIGN was required for
viral capture and internalization by DCs after 2 h at 37
 
 
 
C
(Fig. 2 B). For this purpose, we used a well-characterized
FACS-based assay measuring viral capture through detection
of intracellular p24
 
gag
 
. Strikingly, after 2 h of internalization of
HIV at 37
 
 
 
C (MOI 
 
 
 
 1), we measured similar levels of viral
capture in DC-SIGN
 
 
 
 and DC-SIGN
 
 
 
 DCs. Although
there was a small decrease of viral capture for DC-SIGN 
DCs, it did not reach statistical significance when compared
with DCs transduced with an empty vector (mean   SD:
77   12% vs. 84   5%, respectively; Fig. 2 C). To strengthen
these findings, we trypsinized DCs after viral capture before
FACS analysis to remove surface-bound virus. We observed
identical HIV internalization in DC-SIGN  and DC-SIGN 
DCs after trypsin treatment (unpublished data).
In conclusion, although DC-SIGN promotes binding of
X4 HIV-1 to DCs at 4 C, it is not required for viral cap-
ture and internalization by DCs at 37 C over time.
DC-SIGN Increases Transfer of HIV Infectivity from DCs to
Target Cells in Trans. To investigate whether DC-SIGN
facilitates the transmission of X4 HIV-1 to target cells in
trans, we incubated Raji cells expressing DC-SIGN (LV–
DC-SIGN) or DC-SIGN  Raji cells (LV-si-SIGN8 and
11) with HIV for 2 h (MOI   1) at 37 C and measured
transmission to CD4  HeLa P4-2 cells in a single round in-
fection assay. LV-si-SIGN8 encodes a DC-SIGN–specific
Figure 2. Analysis of HIV binding and capture by DC-SIGN  DCs or
DC-SIGN  DCs. (A) DC-SIGN increases binding of X4 HIV-1 to Raji–
DC-SIGN transfectants or immature DCs. Cells were pulsed with HIV
(100 ng of p24gag) for 2 h at 4 C. Cell-bound virus was determined by a
p24gag ELISA. Results are expressed as percentage of p24gag binding compared
with control cells (Raji-LV–DC-SIGN or untransduced DCs). Mean  
SD of three independent experiments is shown. *, Statistically significant
differences (Student’s t test, P   0.05). (B) DC-SIGN  DCs (LV-siSIGN
11) capture X4 HIV-1 as efficiently as DC-SIGN  DCs. DCs were incu-
bated with X4 HIV-1 at an MOI of 1 for 2 h at 37 C. Cells were immu-
nostained for surface DC-SIGN and labeled with antibodies against intra-
cellular HIV p24gag. The percentage of double positive cells for HIV-p24gag
and DC-SIGN was determined on GFP  cells. One representative exper-
iment out of three is presented. (C) Quantification of HIV internalization
by DC-SIGN  and DC-SIGN  DCs. Results are expressed as the per-
centage of p24gag staining in GFP  DC-SIGN  cells for empty vector-
transduced DCs, or in GFP  DC-SIGN  cells for LV-si-SIGN11-transduced
DCs. Mean   SD of three independent experiments is shown. No statistical
significant difference was observed between DC-SIGN  DCs and DC-
SIGN  DCs (LV-siSIGN 11) (Student’s t test, P   0.05).Arrighi et al. 1283
siRNA, whereas LV-si-SIGN11 downregulates both DC-
SIGN and L-SIGN. LV-si-SIGN26 encodes an inefficient
siRNA (32). DC-SIGN  Raij cells were very efficient in
transferring HIV to target cells, whereas the DC-SIGN–
knocked down Raji cells with either LV-si-SIGN8 or 11
were inefficient to transfer HIV infectivity to target cells
( 70% inhibition; Fig. 3 A). Importantly, this effect did not
result from nonspecific inhibition because it was rescued by
expressing the DC-SIGN homologue L-SIGN in the DC-
SIGN–knocked down Raji cells (condition LV-si-SIGN8  
LV-L-SIGN; Fig. 3 A). The rescue with L-SIGN was par-
tial and correlates with the lower transfer HIV infectivity
mediated by L-SIGN compared with DC-SIGN (41).
Subsequently, we analyzed whether DC-SIGN en-
hanced transfer of HIV infection from primary human DCs
to CD4  HeLa P4-2 cells (Fig. 3 B). Immature DC-
SIGN  DCs showed a decreased capacity to transfer infec-
tious virus to Hela CD4  cells (75% inhibition) compared
with control DCs (Fig. 3 B). In mature DCs, HIV transfer
to target cells was decreased by  40% (Fig. 3 B). It is con-
ceivable that the remaining infectivity transmitted by ma-
ture DC-SIGN  DCs is mediated by additional lectins that
are yet to be identified. Strengthening these findings, we
recently reported that suppressing DC-SIGN from DCs
abrogates their capacity to transmit HIV-1 infectivity to ac-
tivated primary CD4  T cells in trans (32).
Together, these results confirm the role of DC-SIGN as
a crucial HIV receptor that mediates HIV-1 transmission
from DCs to target cells, including activated T cells. Fur-
thermore, we also demonstrate that DC-SIGN enhances
viral transmission in trans downstream from viral capture
because viral capture is equal in DC-SIGN  DCs and in
DC-SIGN  DCs in this system.
DC-SIGN Is Dispensable for the Formation of DC–CD4 
T Cell Clusters. As DC-SIGN is known to interact with
ICAM-3 on resting CD4  T cells, we analyzed whether
disruption of DC-SIGN would prevent formation of clus-
ters between DCs and resting CD4  T cells. A loss of re-
cruitment of T cells by DC-SIGN  DCs could provide an
obvious explanation for the decrease in viral transfer from
DC-SIGN  DCs to T cells.
Figure 3. DC-SIGN facilitates transfer of HIV infectivity to target cells in
trans. (A and B) DC-SIGN–mediated transfer of HIV to CD4  HeLa-P4-2
cells. Raji transfectants expressing DC-SIGN (A) or immature and mature
DCs (B) were transduced with siRNA-expressing lentiviral vectors. DCs or
Raji transfectants expressing DC-SIGN were subsequently sorted into GFP 
DC-SIGN  (LV-si-SIGN8 and 11) and GFP  DC-SIGN  (empty vector,
LV-si-SIGN26). GFP  DC-SIGN  cells (LV-si-SIGN8) were transduced
with L-SIGN (LV-L-SIGN) and are GFP  DC-SIGN  L-SIGN  cells.
Cells were incubated with X4 HIV-1 at an MOI of 1 at 37 C for 2 h. In-
fected cells were loaded onto target CD4  HeLa-P4-2 cells, and transfer of
HIV infectivity was scored in a single round infection assay. Results are
expressed as percentage of the number of infected CD4  HeLa-P4-2
cells compared with control cells (Raji–DC-SIGN [A] or empty vector-
transduced DCs [B]). Mean   SD of three independent experiments is
shown. *, Statistically significant differences (Student’s t test, P   0.05).
Figure 4. DC-SIGN is not required for DC–T cell cluster formation.
(A) Sorted mature DCs (GFP ) were incubated with highly purified rest-
ing CD4  T cells for 30 min at 37 C, allowing DC–T cell cluster forma-
tion. Cell nuclei were stained using DAPI (blue). Arrows denote typical
DC–T cell conjugates. Representative results of three independent exper-
iments are shown. (B) The number of immunological synapses was deter-
mined in each experimental condition by counting on microscope slides.
The percentage of DC–T cell clusters formed by LV-si-SIGN11-transduced
DCs is shown compared with control DCs (empty vector). Mean   SD
of three independent experiments is shown. (C) Kinetics analysis of DC–T
cell cluster formation was performed by flow cytometric analysis. Empty
vector- or LV-si-SIGN11-transduced DCs were incubated over time
with highly purified resting CD4  T cells. DC-SIGN  DCs (LV-siSIGN
11) form DC–T cells conjugates as efficiently as DC-SIGN  DCs.
Mean   SD of three independent experiments is shown.DC-SIGN–mediated Infectious Synapse Formation 1284
First, we measured immunological conjugate formation
between DCs and highly purified resting CD4  T cells by
immunofluorescence analysis. DCs were incubated with
CD4  T cells for 30 min. Cell size and DAPI staining al-
lowed immediate identification of DC–T cell conjugates
(Fig. 4 A). Quantification of the DC–T cell conjugates
demonstrates that DC-SIGN knockdown DCs were able
to form conjugates with T cells as efficiently as untrans-
duced DCs (Fig. 4, A and B).
To further evaluate whether DC-SIGN was required
for the formation of DC-T cells conjugates, we performed
time course experiments using a flow cytometric-based as-
say that allowed us to detect DC–resting CD4  T cell
conjugates. DCs were stained with anti-CD1a mAb, and
CD4  T cells were loaded with a fluorescent dye
(PKH26) or stained with anti-CD3 mAb (Fig. 4 C). Both
T cells staining methods gave identical results (unpublished
data). DC–T cell conjugates were detected as early as 5 or
15 min, and the maximal number of conjugates was de-
tected at 30 min. We did not observe any requirement for
DC-SIGN in the formation of DC–resting CD4  T cell
conjugates.
DC-SIGN Promotes Infectious Synapse Formation between
DCs and CD4  T Cells. DC-SIGN knockdown DCs
form conjugates efficiently with resting CD4  T cells. For
that reason, we investigated whether the abrogated transfer
of HIV infection from DC-SIGN knockdown DCs to T
cells (32) could be explained by a role of DC-SIGN in
DC–T cell infectious synapse formation. We developed the
following infectious synapse assay: DCs pulsed with HIV-1,
containing an HA-tagged integrase (X4 strain), were incu-
bated with highly purified resting CD4  T cells for various
times before fixation and analysis by immunofluorescence
microscopy.
We first analyzed whether DC-SIGN was present in the
infectious synapse between mature DCs and resting CD4 
T cells. DC-SIGN was expressed at high levels in both im-
mature and mature DCs as we reported recently (32). DC-
SIGN could readily be detected at the infectious synapse by
conventional fluorescence microscopy (Fig. 5). Using con-
focal microscopy, we confirmed that DC-SIGN was present
in the infectious synapse (Fig. 5).
Due to the presence of DC-SIGN in the infectious syn-
apse, next we examined whether DC-SIGN was promot-
ing the formation of an infectious synapse between DCs
pulsed with X4 HIV and resting CD4  T cells. Infectious
synapses defined by viral focusing at the DC–T cell contact
site appeared after 10 min of incubation (Fig. 6 B). A larger
proportion of DC–T cell clusters was detected after 30
min, with 60–70% of mature DCs showing viral focusing at
the zone of contact with resting CD4  T cells. When im-
mature DCs were used, only 15–20% of infectious synapses
were formed in DC–T cell clusters and fewer DC–T cells
conjugates were formed between immature DCs and
CD4  T cells (unpublished data), in agreement with previ-
ously published results (8, 27). For this reason, we per-
formed all our infectious synapse experiments using mature
DCs pulsed with HIV. Occasionally, we also observed that
HIV virions were relocalized from intracellular endocytic
compartments to a DC surface distinct from a zone of con-
tact with the T cell (unpublished data). This was possibly
due to an early dissociation between DCs and T cells, and
these events were excluded from subsequent analysis. We
also observed by microscopy that HIV infection was trans-
ferred from mature DCs to resting CD4  T cells because
viral staining was detected on single T cells as well as on T
cells in DC–T cell conjugates in areas that were distinct
from the infectious synapse as observed previously (8). The
amount of viral transfer from DCs to resting CD4  T cells
was difficult to quantify by microscopy; therefore, we mea-
sured infectious synapses in DC–T cell conjugates.
Transduction of DCs with empty lentiviral vectors did
not affect the formation of infectious synapses, with  70%
of mature DC–T cell clusters displaying infectious synapses
(Fig. 6 A, a and b). In contrast, when we used an siRNA
lentiviral vector targeting DC-SIGN expression (LV-si-
SIGN11), infectious synapse formation in DC-SIGN  DC–T
cell clusters was decreased (Fig. 6 A, c and d).
Interestingly, in DC-SIGN  DCs, HIV remained con-
centrated in an intracellular endocytic compartment, even
in the presence of T cells, instead of focusing at the infec-
tious synapse (Fig. 6 A, c and d). This viral pattern was
very similar to DC-SIGN  DCs that had not encountered
T cells (unpublished data). In fact, HIV relocalizes more
efficiently from an intracellular endocytic compartment to
the DC surface upon encountering a T cells in DC-
Figure 5. DC-SIGN is present in the infectious synapse between DCs
and CD4  T cells. Mature DC-SIGN  DCs were loaded with HIV-GFP
for 2 h at 37 C and incubated with highly purified resting CD4  T cells
for 30 min at 37 C, allowing infectious synapse formation. Two represen-
tative examples are shown (a–c and d–f). DC-SIGN was readily detected
at the infectious synapse by confocal microscopy, appearing sometimes
enriched (f), but not consistently (c). (green) HIV-GFP; (red) DC-SIGN.Arrighi et al. 1285
SIGN  DCs (Fig. 6 A, a and b) than in DC-SIGN  DCs
(Fig. 6 A, c and d).
To evaluate if DC-SIGN requirement for infectious syn-
apse formation was rapid, we performed a time course ex-
periment to measure and quantify infectious synapse for-
mation over time. Clearly, the inhibition of HIV transfer to
the infectious synapse was independent of the time used
because 60% inhibition was observed at both 10 and 30
min (Fig. 6 B). Quantitative results at earlier time points
could not be obtained because the number of infectious
synapses formed within that time was too low for analysis.
Nevertheless, this kinetics experiment indicates that DC-
SIGN requirement for infectious synapse formation is rapid
and sustained over time.
Discussion
In this paper, we have demonstrated a novel role for
DC-SIGN downstream from viral capture. This C-type
lectin promotes the formation of an infectious synapse be-
tween DCs pulsed with X4 HIV-1 and resting CD4  T
cells, thereby allowing optimal transfer of HIV infection
from DCs to T cells.
Not only do our results show that DC-SIGN increases
HIV binding on the DCs as reported in several other stud-
ies (7, 8, 10, 11, 17, 32, 42) but, more importantly, our
knockdown system demonstrates that internalization path-
ways in addition to DC-SIGN participate in viral capture
by DCs. These findings are also in agreement with recent
results obtained in an ex vivo model of human cervical tis-
sue explants (7). Interestingly, binding to HIV-gp120 to
DCs appears more dependent on DC-SIGN than full viral
particles (10, 32), suggesting that molecules incorporated in
virions other than HIV gp-120 may enhance binding of
HIV to DCs through a DC-SIGN–independent process
(43, 44). Other DC subtypes, such as Langerhans cells, do
not express DC-SIGN and may bind HIV-1 gp120
through additional molecules such as the Langerin and/or
mannose receptor (14, 16, 45, 46), but whether these mol-
ecules allow for efficient transfer of HIV infection in trans
remains to be established.
Notably, X4 HIV-1 capture and internalization after 2 h
at 37 C by DC-SIGN knockdown DCs was identical to
DC-SIGN  DCs. Our results were obtained with a high
viral input, and we cannot exclude that at a very low viral
input, DC-SIGN would increase viral capture, especially if
the contact between HIV and DCs was over a short period
of time. Nevertheless, our observation indicates that viral
capture occurs efficiently through DC-SIGN–independent
internalization pathways. Although we cannot formally
demonstrate that HIV is stored in the same intracellular
compartment in the presence or absence of DC-SIGN, the
amount of virus captured as well as the morphology of HIV
storage compartment in DC-SIGN  DCs and DC-SIGN 
DCs at immunofluorescence resolution appear very similar
(unpublished data). DC-SIGN–independent viral internal-
ization may be receptor dependent or receptor indepen-
dent. In macrophages, for instance, HIV internalization is
mediated by macropinocytosis in a receptor-independent
manner (47).
Although DC-SIGN does not appear to promote in viral
capture and internalization in our system, this receptor
clearly increases the transfer and enhancement of HIV in-
fection to target cells in trans, especially to CD4  T cells
(32). To evaluate the function of DC-SIGN in the recruit-
ment of resting CD4  T cells, possibly via ICAM-3–DC-
SIGN interactions, we measured the capacity of DC-
SIGN  DCs to form conjugates with resting CD4  T cells.
We could demonstrate that DC-SIGN is dispensable for
DC–resting CD4  T cell conjugate formation. In contrast,
we recently showed that DC-SIGN  DCs did not bind ef-
ficiently to ICAM-3–coated beads (32), suggesting that
other interactions in addition to ICAM-3–DC-SIGN in-
Figure 6. DC-SIGN promotes infectious synapse formation between
DCs and CD4  T cells. (A) Transduced mature DCs were sorted into
GFP  DC-SIGN  (LV-si-SIGN11) or GFP  DC-SIGN  (empty vector)
cells. Sorted mature DCs were loaded with HIV IN-HA for 2 h at 37 C,
and incubated with highly purified resting CD4  T cells for 30 min at
37 C, allowing infectious synapse formation. Representative examples of
infectious synapses obtained between DCs transduced with control lentiviral
vectors and CD4  resting T cells are shown (a and b). DC-SIGN  DCs
(transduced with LV-si-SIGN11) are unable to redistribute internalized
HIV from intracellular pools to the infectious synapse (c and d). (a and c)
Immunofluorescence microscopy. (b and d) Confocal analysis. (green)
GFP-expressing DCs; (red) HIV; (blue) DAPI (nuclei of both DCs and T
cells). (B) Kinetics of infectious synapse formation. Quantification over
time of infectious synapse formation in DC–T cell immunological conju-
gates was performed in DC-SIGN  DCs (transduced with empty vector)
and in DC-SIGN  DCs (transduced with LV-si-SIGN11). Mean   SD
of three independent experiments is shown.DC-SIGN–mediated Infectious Synapse Formation 1286
teractions promote binding of DCs to resting CD4  T
cells.
It has been known for many years that cell-to-cell trans-
mission is the major mode of transfer of HIV infectivity
from DCs to T cells (5, 31). The recent description of an
infectious synapse between DCs pulsed with HIV and T
cells may provide an explanation for DC–T cell retroviral
transmission (8, 27). We have identified in this paper the
first molecule on the DC side of the infectious synapse that
promotes infectious synapse formation, the C-type lectin
DC-SIGN. This unexpected function of DC-SIGN pro-
vides a potential explanation for the high efficiency with
which DCs transfer and enhance X4 HIV-1 infectivity to
T cells in trans. Whether DC-SIGN has a similar function
in the transfer of HIV using CCR5 from DCs to T cells re-
mains to be established.
Although our results provide evidence that DC-SIGN
increases infectious synapse formation, the precise function
of DC-SIGN in this process remains to be determined. We
have shown that DC-SIGN is present in the infectious syn-
apse (Fig. 5). It is conceivable that DC-SIGN recruits in-
ternalized HIV from its storage compartment and rapidly
redirects virions to the plasma membrane, explaining that
HIV focuses at the infectious synapse. Alternatively, when
DC–T cell clusters form, DC-SIGN might mediate a signal
enabling stored virus to reach contact zones with T cells.
The rapid kinetics of HIV transfer to infectious synapses
( 5–10 min), the absence of colocalization of internalized
HIV with DC-SIGN (reference 8 and unpublished data),
and the presence of DC-SIGN in infectious synapses (27)
argues in favor of a signaling model. Indeed, DC-SIGN
might act as a sensor on the surface of DCs. Upon contact
with T cells, DC-SIGN could rapidly send reverse signals
to the DCs that allow internalized antigens to be presented
at the DC surface. Previous studies already demonstrated
that C-type lectins (DC-SIGN and Dectin-1) could modu-
late intracellular signals mediated by Toll receptors (48, 49).
Although DC-SIGN clearly favors infectious synapse
formation, additional components of this machinery remain
to be identified. Whether reorganization of cytoskeleton is
required as shown for HTLV-1 and HIV-1 spread between
T lymphocytes is still unsolved (references 50, 51 and for
review see reference 28).
In conclusion, our paper provides a new insight into the
mechanisms of transfer of infectious virus from DCs to T
cells via an infectious synapse, a step that is critical for HIV
transmission and pathogenesis.
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